EPS for Madrigal Pharmaceuticals, Inc. (MDGL) Expected At $-0.75; Hl Financial Services Raised By $502,588 Its Omnicom Group (OMC) Stake

Omnicom Group Inc. (NYSE:OMC) Logo

Hl Financial Services Llc increased Omnicom Group (OMC) stake by 0.65% reported in 2018Q3 SEC filing. Hl Financial Services Llc acquired 7,391 shares as Omnicom Group (OMC)’s stock rose 8.95%. The Hl Financial Services Llc holds 1.15 million shares with $78.36 million value, up from 1.14 million last quarter. Omnicom Group now has $16.47B valuation. The stock decreased 0.81% or $0.6 during the last trading session, reaching $73.49. About 3.41M shares traded or 46.72% up from the average. Omnicom Group Inc. (NYSE:OMC) has risen 3.76% since February 13, 2018 and is uptrending. It has outperformed by 3.76% the S&P500. Some Historical OMC News: 27/03/2018 – Omnicom to Buy Elsevier’s Pharma Communications Business in Japan; 17/04/2018 – Omnicom Grows, Despite Continuing Client Pressures; 22/03/2018 – Omnicom Hosts Its Own Upfront, Turning Table on Media Sellers; 22/05/2018 – HSBC Global Media Account Moves From WPP to Omnicom; 17/04/2018 – Omnicom 1Q EBITA $449.2M; 07/03/2018 – TBWA\Chiat\Day New York Hires Lawson Waring as Global Brand Leader; Alberto Botero as Head of Data; 27/03/2018 – OMNICOM HEALTH GROUP – ACQUIRED BUSINESS & EMPLOYEES WILL BECOME PART OF NEWLY-NAMED HEALTHCARE MARKETING COMMUNICATIONS AGENCY, EMC K.K; 09/05/2018 – TBWA\Chiat\Day New York Taps Al Merry for Executive Creative Director Role; 12/03/2018 – GSD&M IDEA CITY WINS $741 MLN U.S. DEFENSE CONTRACT -PENTAGON; 17/04/2018 – Omnicom 1Q Income Tax Expense Reduced by $13M

Analysts expect Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) to report $-0.75 EPS on March, 12.They anticipate $0.08 EPS change or 11.94% from last quarter’s $-0.67 EPS. After having $-0.56 EPS previously, Madrigal Pharmaceuticals, Inc.’s analysts see 33.93% EPS growth. The stock decreased 1.63% or $1.96 during the last trading session, reaching $118.14. About 239,015 shares traded. Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) has risen 37.05% since February 13, 2018 and is uptrending. It has outperformed by 37.05% the S&P500. Some Historical MDGL News: 31/05/2018 – MADRIGAL PHARMACEUTICALS INC – IN PHASE 2 CLINICAL TRIAL, MGL-3196 DEMONSTRATED STATISTICAL SIGNIFICANCE IN PRIMARY ENDPOINT; 31/05/2018 – STAT Plus: With positive data, Madrigal Pharma joins lucrative race for drug to treat fatty liver disease; 13/03/2018 – MADRIGAL PHARMACEUTICALS INC – QTRLY SHR LOSS $0.67; 08/05/2018 – MADRIGAL PHARMA 1Q LOSS/SHR 45C, EST. LOSS/SHR 78C; 15/05/2018 – Capital Group Companies Buys 7.4% Position in Madrigal Pharma; 13/03/2018 – Madrigal Pharmaceuticals 4Q Rev $0.00; 08/05/2018 – Madrigal Pharmaceuticals 1Q Loss/Shr 45c; 31/05/2018 – MADRIGAL PHARMACEUTICALS -PHASE 2 CLINICAL TRIAL OF MGL-3196 ALSO SHOWED STATISTICALLY SIGNIFICANT RESULTS IN KEY SECONDARY ENDPOINTS; 31/05/2018 – Madrigal’s MGL-3196 Achieves Liver Biopsy Endpoints in Patients with Non-alcoholic Steatohepatitis (NASH) at 36 Weeks in Phase 2 Clinical Trial; 19/03/2018 – Madrigal Pharma at Investor Day Hosted By H.C. Wainwright Today

More notable recent Omnicom Group Inc. (NYSE:OMC) news were published by: Gurufocus.com which released: “First Eagle Investment Trims Omnicom, Microsoft Positions – GuruFocus.com” on February 13, 2019, also Bizjournals.com with their article: “Jim Beam launches ‘Raised Right’ ad campaign (Video) – Chicago Business Journal” published on February 13, 2019, Benzinga.com published: “12 Stocks To Watch For February 12, 2019 – Benzinga” on February 12, 2019. More interesting news about Omnicom Group Inc. (NYSE:OMC) were released by: Seekingalpha.com and their article: “Ad giants slip after Publicis revenue disappointment – Seeking Alpha” published on February 06, 2019 as well as Businesswire.com‘s news article titled: “Interbrand and Zuora Join Forces to Help Global Brands Succeed in the Subscription Economy – Business Wire” with publication date: February 13, 2019.

Investors sentiment decreased to 0.83 in 2018 Q3. Its down 0.17, from 1 in 2018Q2. It fall, as 49 investors sold OMC shares while 234 reduced holdings. 69 funds opened positions while 165 raised stakes. 226.63 million shares or 1.94% less from 231.12 million shares in 2018Q2 were reported. Zacks Mgmt accumulated 0.04% or 29,123 shares. Of Vermont invested 0.01% of its portfolio in Omnicom Group Inc. (NYSE:OMC). Bank & Trust Of America De has 686,934 shares. Motco stated it has 240 shares or 0% of all its holdings. Nuveen Asset Management Limited Liability Corporation invested in 0.01% or 29,893 shares. Riverhead Limited Liability Company stated it has 93,229 shares or 0.23% of all its holdings. Eagle Asset reported 340,204 shares. Transamerica Financial Advisors Incorporated invested 0% in Omnicom Group Inc. (NYSE:OMC). Alabama-based Oakworth Incorporated has invested 0.01% in Omnicom Group Inc. (NYSE:OMC). Cap Guardian Trust has 0% invested in Omnicom Group Inc. (NYSE:OMC). Mariner Ltd Limited Liability Company accumulated 14,122 shares or 0.02% of the stock. Kempen Cap Management Nv has invested 1.67% in Omnicom Group Inc. (NYSE:OMC). Cibc World Mkts Incorporated reported 198,433 shares. Professional Advisory Inc, Florida-based fund reported 199,526 shares. Jane Street Group Limited reported 289,348 shares.

Since October 18, 2018, it had 0 insider purchases, and 4 selling transactions for $1.10 million activity. 533 shares were sold by RICE LINDA JOHNSON, worth $40,657 on Thursday, October 18. On Friday, October 19 the insider Nelson Jonathan B. sold $1.01M. Hewitt Dennis E. sold 500 shares worth $37,924.

Hl Financial Services Llc decreased First Tr Emerging Etf (FEM) stake by 25,084 shares to 287,164 valued at $7.20 million in 2018Q3. It also reduced Vanguard Small Cap Etf (VB) stake by 13,969 shares and now owns 154,495 shares. Ishares Jp Morgan Etf (EMB) was reduced too.

More notable recent Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) news were published by: Benzinga.com which released: “26 Stocks Moving In Tuesday’s Pre-Market Session – Benzinga” on February 12, 2019, also Seekingalpha.com with their article: “Viking Therapeutics, Madrigal move up as Gilead liver drug fails to meet goals – Seeking Alpha” published on February 11, 2019, Nasdaq.com published: “Gilead’s (GILD) Late-Stage Study on Liver Disease Drug Fails – Nasdaq” on February 12, 2019. More interesting news about Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) were released by: Seekingalpha.com and their article: “UBS likes Lilly in premarket analyst action – Seeking Alpha” published on January 23, 2019 as well as Seekingalpha.com‘s news article titled: “Viking Therapeutics: Anatomy Of A Multi-Bagger – Seeking Alpha” with publication date: January 15, 2019.

Omnicom Group Inc. (NYSE:OMC) Institutional Positions Chart